
Junction Bioscience
Junction Bioscience is a YC Winter 2024 (W24) company. Team of 1.
About Junction Bioscience
Summary
Junction Bioscience builds an autonomous AI system that generates and iterates on scientific hypotheses to guide small-molecule drug discovery. It targets the neuroinflammation and immunology space, where the platform works to map the molecular drivers of disease and identify therapeutic candidates. The work it replaces is the slow, largely manual cycle of hypothesis generation and experimental design that characterizes early-stage medicinal chemistry research.
From the Y Combinator listing
AI Hypothesis Engine for Molecular Discovery
Junction Bioscience is building an autonomous AI scientist to navigate the discovery of transformative medicines. Our scientific hypothesis engine iterates upon breakthrough chemistry from the laboratory to achieve clarity and control over the molecular basis of disease. We focus on the intersection of neuroinflammation and immunology where uncommon molecular insights position us to develop best-in-class therapies for millions of patients in need.
Facts
- Healthcare / Healthcare -> Therapeutics
- 1
- Active
- Early
Founders (1)
- Brian Petkov
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works